The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome
More about Open Access at the CrickAbstract
The advent of rapid and inexpensive sequencing technology allows scientists to decipher heterogeneity within primary tumours, between primary and metastatic sites, and between metastases. Charting the evolutionary history of individual tumours has revealed drivers of tumour heterogeneity and highlighted its impact on therapeutic outcomes.
Full text links
Publisher website (DOI) 10.1186/s12916-017-0900-y
Europe PubMed Central 28716075
Pubmed 28716075
Keywords
Related topics
Type of publication